heparin: be used during invasive surgeries

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.72
, blood
Weight: 0.57
, agent
Weight: 0.56
, molecule
Weight: 0.56
Siblings acetaminophen
Weight: 0.37
, fentanyl
Weight: 0.37
, warfarin
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be used during invasive surgeries 1.00
be used during surgeries 0.93
be used in surgery 0.88
be used in cardiac surgery 0.83
be given before surgery 0.81
be given to dialysis patients 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.76
¬ Salient(heparin, be used during invasive surgeries)

Similarity expansion

0.70
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.93
Evidence: 0.76
Typical(heparin, be used during invasive surgeries)
Evidence: 0.49
¬ Typical(heparin, be used during surgeries)
0.68
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.93
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.59
¬ Salient(heparin, be used during surgeries)
0.68
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.93
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.50
¬ Plausible(heparin, be used during surgeries)
0.67
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.88
Evidence: 0.76
Typical(heparin, be used during invasive surgeries)
Evidence: 0.44
¬ Typical(heparin, be used in surgery)
0.65
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.52
¬ Salient(heparin, be used in surgery)
0.65
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.88
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.45
¬ Plausible(heparin, be used in surgery)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.52
¬ Salient(heparin, be given before surgery)
0.60
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.56
Remarkable(heparin, be used during invasive surgeries)
Evidence: 0.30
¬ Remarkable(heparin, be given before surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.83
Evidence: 0.76
Typical(heparin, be used during invasive surgeries)
Evidence: 0.81
¬ Typical(heparin, be used in cardiac surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.81
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.63
¬ Plausible(heparin, be given before surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.83
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.83
¬ Salient(heparin, be used in cardiac surgery)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.76
Typical(heparin, be used during invasive surgeries)
Evidence: 0.82
¬ Typical(heparin, be given before surgery)
0.56
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.93
Evidence: 0.56
Remarkable(heparin, be used during invasive surgeries)
Evidence: 0.68
¬ Remarkable(heparin, be used during surgeries)
0.55
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.83
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.76
¬ Plausible(heparin, be used in cardiac surgery)
0.53
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.88
Evidence: 0.56
Remarkable(heparin, be used during invasive surgeries)
Evidence: 0.66
¬ Remarkable(heparin, be used in surgery)
0.52
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.83
Evidence: 0.56
Remarkable(heparin, be used during invasive surgeries)
Evidence: 0.61
¬ Remarkable(heparin, be used in cardiac surgery)
0.50
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.90
¬ Salient(heparin, be given to dialysis patients)
0.50
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.76
Typical(heparin, be used during invasive surgeries)
Evidence: 0.94
¬ Typical(heparin, be given to dialysis patients)
0.50
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.56
Remarkable(heparin, be used during invasive surgeries)
Evidence: 0.50
¬ Remarkable(heparin, be given to dialysis patients)
0.48
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.75
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.87
¬ Plausible(heparin, be given to dialysis patients)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.76
Salient(heparin, be used during invasive surgeries)
Evidence: 0.76
¬ Typical(heparin, be used during invasive surgeries)
Evidence: 0.56
¬ Remarkable(heparin, be used during invasive surgeries)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.71
Plausible(heparin, be used during invasive surgeries)
Evidence: 0.76
¬ Typical(heparin, be used during invasive surgeries)